Drugs / HPV16 E7 peptide-pulsed autologous DCs
HPV16 E7 peptide-pulsed autologous DCs
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00155766 | Jan 2003 → Mar 2006 | cervical cancer | National Taiwan University Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HPV16 E7 peptide-pulsed autologous DCs | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00155766 ↗ |
| Modality | Cell therapy | “antigen-pulsed autologous dendritic cells” NCT00155766 ↗ |
| Route | Other | “Antigen-pulsed dendritic cells will be injected into inguinal lymph nodes” NCT00155766 ↗ |